Inozyme Pharma, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INZY research report →
About the company
Inozyme Pharma, Inc. operates as a biopharmaceutical entity dedicated to addressing rare diseases. Its primary mission involves pioneering treatments for disorders characterized by aberrant mineralization, which impacts the body's vascular system, soft tissues, and skeletal structure.
- CEO
- Douglas A. Treco
- IPO
- 2020
- Employees
- 67
- HQ
- Boston, MA, US
Price Chart
- Market Cap
- $258.25M
- P/E
- -2.47
- P/S
- 0.00
- P/B
- 4.34
- EV/EBITDA
- -2.73
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -102.90%
- ROIC
- -99.36%
- Revenue
- $0 · 0.00%
- Net Income
- $-102,024,000 · -43.35%
- EPS
- $-1.62 · -18.25%
- Op Income
- $-104,030,000
- FCF YoY
- -29.58%
- 52W High
- $6.24
- 52W Low
- $0.72
- 50D MA
- $2.85
- 200D MA
- $2.79
- Beta
- 2.29
- Avg Volume
- 2.26M
Get TickerSpark's AI analysis on INZY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 1, 25 | Subramanian Sanjay | sell | 180,000 |
| Jul 1, 25 | Subramanian Sanjay | sell | 135,000 |
| Jul 1, 25 | Subramanian Sanjay | sell | 145,000 |
| Jul 1, 25 | Subramanian Sanjay | other | 39,701 |
| Jul 1, 25 | Subramanian Sanjay | sell | 38,500 |
| Jul 1, 25 | Winton Matthew | sell | 145,000 |
| Jul 1, 25 | Winton Matthew | other | 21,743 |
| Jul 1, 25 | Winton Matthew | sell | 41,500 |
| Jul 1, 25 | Bolte Axel | other | 423,926 |
| Jul 1, 25 | Bolte Axel | sell | 234,176 |
Our INZY coverage
Recent articles, reports, and earnings notes.
No research on INZY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate INZY report →Similar companies
Peers in the same neighborhood.